We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BTX market cap is 52.96M. The company's latest EPS is USD -4.0081 and P/E is -0.07.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 51k | 17k | 47k | 47k |
| Operating Income | -4.6M | -5.51M | -5.77M | -5.79M | -4.93M |
| Net Income | -4.52M | -5.59M | -6.16M | -6.65M | -5.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 19.81M | 5.8M | 0 | 0 | 68k |
| Operating Income | -1.76M | -6.31M | -113.73M | -27.23M | -21.14M |
| Net Income | -2.06M | -4.43M | -122.32M | -24.6M | -21.68M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 46.95M | 52.25M | 49.13M | 49.66M | 46.49M |
| Total Liabilities | 43.09M | 48.69M | 46.9M | 53.07M | 55.01M |
| Total Equity | 3.87M | 3.56M | 2.23M | -3.41M | -8.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.13M | 3.75M | 32.43M | 22.28M | 49.13M |
| Total Liabilities | 9.03M | 2.89M | 25.93M | 10.17M | 46.9M |
| Total Equity | 5.09M | 851k | 6.5M | 12.11M | 2.23M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.92M | -15.75M | -20.41M | -3.75M | -6.01M |
| Investing | N/A | N/A | -19k | -97k | -346k |
| Financing | 312k | 8.85M | 16.56M | 1.39M | 1.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.74M | -3.89M | -23.49M | -20.98M | -20.41M |
| Investing | -1.07M | 960k | -22.74M | -47k | -19k |
| Financing | -1.1M | 291k | 61.59M | 19.58M | 16.56M |
| Market Cap | 52.96M |
| Price to Earnings Ratio | -0.07 |
| Price to Sales Ratio | 23.02 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | 0.7 |
| Dividend Yield | - |
| Shares Outstanding | 5.41M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.22 (2.25%) |
| Company Name | Brooklyn ImmunoTherapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://eternatx.com |
| Industry | television broadcast station (4833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
